When you've watched your child push through physical therapy sessions and the progress is still slow, the waiting has a particular weight to it. You understand the limits. You know the brain changes carefully. And still, you find yourself searching: is there anything else?

If you've come across the Trexo robotic gait trainer in that search, here's what you need to know: not a sales pitch, but a clear-eyed look at what the device does, who it helps, what the research says, and what it realistically costs to access.

What the Trexo Robotic Gait Trainer Is

Trexo is a pediatric robotic gait trainer designed for home and clinical use. It supports children as young as 18 months and up to 100 pounds. The device consists of motorized leg braces that attach to the child's legs, a harness system for partial weight support, and a base unit that the child moves through. Caregivers operate it via a touchscreen tablet, adjusting speed, step length, and the amount of weight support.

It connects to the child's existing walker or gait trainer. It doesn't replace their current equipment; it supplements it by enabling walking practice when a child doesn't yet have the strength or coordination to initiate movement on their own. It is FDA listed as a Class I medical device in the United States and has Health Canada approval. Primary users include children with cerebral palsy, spina bifida, muscular dystrophy, and other conditions that affect mobility.

How Robotic Gait Training Works

Walking involves an enormous amount of neurological coordination happening faster than any of us consciously experience. For children with conditions like cerebral palsy, the signals between the brain and muscles are disrupted or incomplete, meaning the walking pattern doesn't develop the way it does for other children, no matter how motivated they are.

Robotic gait training works differently than traditional therapy. Rather than building isolated muscle strength, it moves the legs through a complete walking pattern repeatedly, giving the nervous system the experience of taking steps even before the child can generate those steps independently. The underlying theory is neuroplasticity: that repetitive, patterned movement, especially during early childhood when the brain is most adaptable, can help form or strengthen the neural pathways associated with walking.

Therapists call this task-specific training. The child isn't just building strength on a mat; they're practicing the actual movement, in context, with the mechanical support the device provides.

Who It's Designed For

Trexo is designed for children with mobility disabilities who have some ability to bear weight on their legs but cannot walk independently. Children with the following conditions are the primary candidates:

• Cerebral palsy at all GMFCS levels; children at levels IV and V make up the majority of users
• Spina bifida
• Muscular dystrophy
• Genetic conditions affecting muscle tone or motor coordination
• Brain injuries that have affected mobility

Children who cannot tolerate being upright, have severe contractures that prevent leg movement, or fall outside the device's supported weight and height range are not appropriate candidates.

Families most often consider Trexo when traditional therapy has plateaued, when their child is aging out of early intervention but still has significant mobility goals, or when they want to increase the frequency of gait practice without scheduling clinic sessions for every session.

What the Research Shows

It's worth knowing where the evidence stands, because Trexo is still a relatively new intervention and the research reflects that.

A 2020 study in Developmental Medicine & Child Neurology followed 13 children using Trexo at home over 12 weeks. Researchers measured gross motor function using the GMFM-66, a standardized assessment for children with cerebral palsy. The average improvement was 2.6 points, which is considered clinically meaningful. Parents also noted improvements in sitting balance and standing tolerance, which weren't even the primary outcomes being measured. A 2021 follow-up found that families who used the device consistently over six months reported sustained motor gains, and that home-based sessions happened more regularly than clinic-based ones because they removed travel and scheduling barriers.

The results are encouraging, and they come with real limitations. Both studies have small sample sizes and no control groups, which makes it difficult to isolate exactly what Trexo contributes versus other factors like developmental maturation or concurrent therapies. Larger trials are needed before we can say with certainty how it compares to conventional therapy alone.

What the research does support: the device is safe for home use, children tolerate it well, and it increases total gait practice time. That last piece matters for families who want more intensive practice than clinic schedules can realistically provide.

Cost and Insurance

Trexo is expensive, and coverage is inconsistent. Both things are true, and families deserve to understand that before they invest time in the process.

The device costs approximately $45,000 to purchase or around $900 per month to lease. Some private insurers have approved coverage under durable medical equipment policies, and Trexo provides a letter of medical necessity template and support through the appeals process. Approval isn't guaranteed, and the process often takes months.

Medicaid coverage varies by state. A handful of states have approved funding through waiver programs; most have not. Families who've had success typically frame it as medically necessary equipment prescribed by a physician and supported by documentation from their physical therapist, but this requires persistence and often multiple appeals.

For families who can't secure insurance coverage, Trexo offers financial assistance and connects families to assistive technology grant programs. Some families have used fundraising platforms to close the gap. Navigating all of this is an added burden on families who are already carrying a lot, and it's worth going in with a realistic picture of what the path looks like.

Where to Access Trexo

Trexo is available for home use in the United States and Canada. Families typically begin by contacting the company directly. A physician prescription and physical therapist assessment are required to confirm candidacy. Once approved, Trexo sends a representative to the home to deliver and fit the device and train caregivers on how to use it.

Some pediatric therapy clinics and rehabilitation centers have Trexo available for in-clinic sessions, which is a valuable option for families who want to try the device before committing, or who aren't ready for a home lease. A growing number of nonprofit organizations also run equipment lending programs that allow families to borrow a device for a short trial period, typically one to three months.

If you're exploring access options, starting with a trial through a clinic or lending program is often the most practical path.

Before You Commit

Robotic gait trainers are tools, not cures, and this one in particular requires honest reflection before committing. The device needs dedicated space in your home and regular use, typically 20 to 30 minutes per session, three to five times per week, with a caregiver present every time. Some children engage enthusiastically. Others tolerate it. There's no way to know without a trial.

It's also worth talking with your physical therapist about whether gait training fits your child's current goals. If your child is working primarily on sitting balance, hand function, or communication, intensive gait practice might not be the highest priority right now. Therapy time and energy are finite, and the best intervention is the one that fits where your child is developmentally, not just the most advanced technology available.

What This Technology Offers

For families who can access it, Trexo can meaningfully increase how much gait practice a child receives, and that consistency matters. It doesn't change the underlying neurological or muscular condition, but it creates more opportunities for the nervous system to practice the pattern it's trying to learn.

What it asks of families is significant: time, caregiving involvement, advocacy through insurance systems, and often financial creativity. Families who've found a way through describe it as worth it when the child responds. Others have found that the logistical and financial weight wasn't the right fit for where their family is, and that's a reasonable conclusion too.

You know your child and your family's bandwidth. The goal is to find the right tool for this child, right now. If Trexo is worth exploring, start with a trial. If it's not the right time, that's information, not failure.